Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirena for Isthmocele Symptoms
NCT04872244Completed
- Sponsor
- Gaziosmanpaşa Training and Research Hospital
- Start
- Nov 2019
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of avatrombopag in cesarean scar defect (CSD), sponsored by Gaziosmanpaşa Training and Research Hospital. Primary endpoints: Incidence of postmenstrual spotting bleeding at 18 months, Incidence of dysmenorrhea at 18 months and 1 more. Started Nov 2019; status: completed.
02
Drugs
avatrombopag
03
Conditions
cesarean scar defect (CSD)
Beyond the preview
Go deeper on NCT04872244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04872244.